In contrast, IL-2 treatment attenuated and even reversed depression- and anxiety-like behaviors by normalizing the deficiency of monoamine neurotransmitters and the increase in neurotransmitter metabolism in the hippocampus and amygdala. The gene discussed is IL2; the disease is depressive symptom measurement.